Extract notice to the Minister

NB-Irbesartan

Common name / Subject : irbésartan
Name of the manufacturer : NB Pharma
Form : Co.
Dosage : 75 mg, 150 mg, 300 mg

Indication :

INESSS' Recommendation
Inscription

Minister's decisions
Inscrire sur les listes des médicaments (2026-07-30)

Evaluation published on July 28, 2026

Subscribe to our newsletter now

Subscription